MiSight 1 day, the world’s first daily disposable contact lens for myopia management, recently became the first and only US Food and Drug Administration-approved product clinically proven to slow the progression of myopia.
Three-year peer-reviewed results indicated that use of the CooperVision contact lens slowed myopia progression by 59% as measured by mean cycloplegic spherical equivalent and 52% as measured by mean axial elongation of the eye.
First made available in Hong Kong in 2009, MiSight is also being distributed with a ‘myopia control indication’ in eight European countries, the Nordic region, Israel, Canada, Singapore, Malaysia and Australasia.
Email: MiSight1day@au.coopervision.com
